[PDF][PDF] SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses
On 24 th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529
was announced, containing far more mutations in Spike (S) than previously reported …
was announced, containing far more mutations in Spike (S) than previously reported …
Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study
…, HE Hardwick, S Halpin, M Girvan, C Donohue… - bmj, 2020 - bmj.com
Objective To characterise the clinical features of children and young people admitted to
hospital with laboratory confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…
hospital with laboratory confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…
[HTML][HTML] Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP …
…, C Palmieri, M Zambon, H Hardwick, C Donohue… - The Lancet …, 2021 - thelancet.com
Background Microbiological characterisation of co-infections and secondary infections in
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …
[HTML][HTML] Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation …
Background This study sought to establish the long-term effects of Covid-19 following
hospitalisation. Methods 327 hospitalised participants, with SARS-CoV-2 infection were recruited …
hospitalisation. Methods 327 hospitalised participants, with SARS-CoV-2 infection were recruited …
[HTML][HTML] Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort …
…, M Zambon, H Hardwick, C Donohue… - The Lancet …, 2021 - thelancet.com
Background Studies of patients admitted to hospital with COVID-19 have found varying
mortality outcomes associated with underlying respiratory conditions and inhaled corticosteroid …
mortality outcomes associated with underlying respiratory conditions and inhaled corticosteroid …
[HTML][HTML] Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study
…, M Zambon, H Hardwick, C Donohue… - The Lancet …, 2021 - thelancet.com
Background Prognostic models to predict the risk of clinical deterioration in acute COVID-19
cases are urgently required to inform clinical management decisions. Methods We …
cases are urgently required to inform clinical management decisions. Methods We …
[HTML][HTML] Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective …
Background COVID-19 is a multisystem disease and patients who survive might have in-hospital
complications. These complications are likely to have important short-term and long-…
complications. These complications are likely to have important short-term and long-…
[HTML][HTML] Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective …
…, LCW Turtle, M Zambon, C Donohue… - The Lancet …, 2021 - thelancet.com
Background Early in the pandemic it was suggested that pre-existing use of non-steroidal
anti-inflammatory drugs (NSAIDs) could lead to increased disease severity in patients with …
anti-inflammatory drugs (NSAIDs) could lead to increased disease severity in patients with …
[HTML][HTML] Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation …
…, M Zambon, H Hardwick, C Donohue… - The Lancet …, 2021 - thelancet.com
Background Mortality rates in hospitalised patients with COVID-19 in the UK appeared to
decline during the first wave of the pandemic. We aimed to quantify potential drivers of this …
decline during the first wave of the pandemic. We aimed to quantify potential drivers of this …
What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol
…, M Hashmi, AM Dyrhol-Riise, C Donohue… - BMJ open, 2021 - bmjopen.bmj.com
Introduction Very little is known about possible clinical sequelae that may persist after
resolution of acute COVID-19. A recent longitudinal cohort from Italy including 143 patients …
resolution of acute COVID-19. A recent longitudinal cohort from Italy including 143 patients …